Aeglea BioTherapeutics Reports First Quarter 2023 Financial Results

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) today announced financial results for the first quarter 2023. First Quarter 2023 Financial Results...

Related Keywords

France ,Texas ,United States ,Aeglea Biotherapeutics ,European Medicines Agency ,Biotherapeutics Inc ,Company Annual Report On Form ,Nasdaq ,Exchange Commission ,Company Quarterly Report On Form ,Aeglea Biotherapeutics Inc ,Immedica Pharma ,Middle East ,Supply Agreement ,Biologics License Application ,Marketing Authorization Application ,European Medicines ,Forward Looking ,Securities Litigation Reform Act ,Annual Report ,Quarterly Report ,United States Securities ,Nc ,